HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | 0.0% | 151 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | -100.0% | 151 | -100.0% | 0.00% | -100.0% |
| Q1 2022 | $31,689,000 | -17.5% | 651,372 | -27.7% | 2.15% | +1.1% |
| Q4 2021 | $38,411,000 | -47.3% | 900,824 | -52.6% | 2.12% | -32.7% |
| Q3 2021 | $72,859,000 | -3.2% | 1,900,824 | -28.7% | 3.16% | +13.0% |
| Q2 2021 | $75,274,000 | -14.6% | 2,666,456 | -0.1% | 2.79% | -10.9% |
| Q1 2021 | $88,180,000 | -8.6% | 2,668,897 | 0.0% | 3.13% | +8.0% |
| Q4 2020 | $96,481,000 | +6.6% | 2,668,897 | 0.0% | 2.90% | -3.7% |
| Q3 2020 | $90,476,000 | – | 2,668,897 | – | 3.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |